Skip to Main Content

Paper Details

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo.
bioRxiv
33
2020
D614G, D614G variant, S protein, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 neutralizing antibodies, SARS-CoV2, Syrian hamsters, human, human ACE2, mice, nanoluciferase, primary human proximal airway epithelial cells, pulmonary disease
Author NameAffiliation
Camille EhreMarsico Lung Institute, University of North Carolina at Chapel Hill
Sarah R LeistUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Richard C BoucherMarsico Lung Institute, University of North Carolina at Chapel Hill
Scott H RandellMarsico Lung Institute, University of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Yoshihiro KawaokaInstitute of Medical Science, University of Tokyo
Yoshihiro KawaokaInfluenza Research Institute, University of Wisconsin
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
  • 1 - 13

Datasets

Release 1.2